Nucleic acid amplification tests for Yersinia pestis detection: A comprehensive technical and field-oriented review
Mahsa Khosrojerdi1, Seyed Ahmad Hashemi2, Reza Besharati3
1Department of Immunology and Allergy, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Journal of Microbiological Methods
|July 7, 2026
Summary
This review compares nucleic acid amplification tests (NAATs) for diagnosing plague, a deadly zoonotic disease. It details various NAATs, their performance, and readiness for point-of-care use to aid in diagnosis and outbreak control.
Area of Science:
- Medical Microbiology
- Molecular Diagnostics
- Zoonotic Diseases
Background:
- Plague, caused by Yersinia pestis, is a severe zoonotic disease with global foci.
- Accurate and rapid diagnostics are crucial for patient outcomes and controlling outbreaks.
- Nucleic acid amplification tests (NAATs) are key diagnostic tools for plague.
Purpose of the Study:
- To provide a comprehensive technical comparison of various NAATs for Yersinia pestis detection.
- To evaluate the analytical performance, clinical validation, and point-of-care readiness of different NAAT platforms.
- To identify challenges and future directions in plague diagnostics.
Main Methods:
- Review of conventional PCR, real-time PCR, isothermal methods (LAMP, RPA), droplet digital PCR, and CRISPR-based platforms.
- Analysis of analytical performance metrics including limit of detection, sensitivity, and specificity.
- Evaluation of clinical validation in human specimens and applications in environmental and vector surveillance.
Main Results:
- Detailed comparison of NAAT technologies, highlighting their strengths and limitations.
- Summary of performance data and clinical utility across different diagnostic platforms.
- Identification of key challenges in sample preparation, target selection, and multiplexing.
Conclusions:
- NAATs have significantly advanced plague diagnostics, offering diverse options for various settings.
- Point-of-care readiness varies among platforms, with ongoing development towards more accessible solutions.
- Future advancements may involve AI integration and novel formats like lyophilized CRISPR tests for improved plague detection and management.


